This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Morning Briefing: 10 Things You Should Know

Stocks in this article: OMCPRGOELNJPMAAPLHTZWYNN

NEW YORK ( TheStreet) -- Here are 10 things you should know for Monday, July 29:

1. -- U.S. stock futures were pointing lower Monday ahead of a two-day meeting this week of the Federal Reserve and the U.S. jobs report for July on Friday.

European stocks were trading trading mixed Monday while Asian shares ended the session with losses. Japan's Nikkei 225 index dropped 3.3% to 13,661.13, as the yen rose.


2. -- The economic calendar in the U.S. Monday includes pending home sales for June at 10 a.m. EDT.


3. -- U.S. stocks on Friday rose but posted their first weekly decline in July as investors balked at surpassing the 1,700 level on the S&P 500, unsure about the strength of the U.S. economic recovery and the Federal Reserve's commitment to maintain its stimulus program.

The S&P 500 rose 0.08% on Friday to 1,691.65 but slipped 0.03% for the week. The Dow Jones Industrial Average added 0.02% to 15,559.20, and added 0.1% for the week. The Nasdaq finished up 0.22% at 3,613.16 and gained 0.22% for the week.


4. -- Omnicom (OMC) and France's Publicis agreed to a merger that would create the world's largest advertising firm.

The deal -- which combines the companies in a "merger of equals" -- is valued at around $35.1 billion.

The combined company will be called Publicis Omnicom Group and be led jointly by Omnicom CEO John Wren and Publicis CEO Maurice Levy as co-chief executives.

The companies said they expect the deal to overcome any regulatory hurdles in the U.S. and Europe. They also would have to overcome any client conflicts since rivals such as Coca-Cola and PepsiCo, and Johnson & Johnson and Procter & Gamble, now find themselves under the same umbrella.


5. -- Michigan-based drugmaker Perrigo (PRGO) reached a deal to buy Ireland's Elan (ELN) for $8.6 billion.

Perrigo said it will pay Elan investors $6.25 a share in cash and $10.25 in Perrigo stock. The deal is 11% premium over Elan's closing price Friday.

Perrigo said it will become an Irish-based company and said it could cut its tax liabilities nearly in half, saving more than $150 million a year.


6. -- JPMorgan Chase (JPM) said it will explore the sale of its physical commodities business.

Other strategic alternatives include a spinoff or a strategic partnership.

JPMorgan said Friday that during the process it will continue to operate the business as a going concern. The bank also said it remains committed to traditional activities in the commodities market, including financial derivatives and the vaulting and trading of precious metals.


7. -- Apple (AAPL) veteran Bob Mansfield, senior vice president of technologies, "is no longer going to be on Apple's executive team" but will remain at the iPod and iPhone maker "working on special projects" reporting to Tim Cook, an Apple spokesman told The Wall Street Journal.

The newspaper noted that on Sunday Mansfield's biography information had disappeared from the company's Web site. The Journal said Apple in the past has removed biographies from its Web site as executive shakeups happen.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs